Entero Healthcare Solutions shines on getting nod to acquire 80% stake in Bioaide Technologies
Entero Healthcare Solutions is currently trading at Rs 1186.80, up by 49.40 points or 4.34% from its previous closing of Rs 1137.40 on the BSE.
The scrip opened at Rs 1159.85 and has touched a high and low of Rs 1200.00 and Rs 1125.00 respectively. So far 12889 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52-week high of Rs 1564.95 on 05-Feb-2025 and a 52-week low of Rs 1038.80 on 07-Nov-2025.
Last one week high and low of the scrip stood at Rs 1200.00 and Rs 1038.80 respectively. The current market cap of the company is Rs 5143.19 crore.
The promoters holding in the company stood at 52.42%, while Institutions and Non-Institutions held 24.32% and 23.26% respectively.
Entero Healthcare Solutions has received approval from Board of Directors for execution of definitive agreements for acquiring 80% stake in Bioaide Technologies (Bioaide). The business of Bioaide is in line with the business of the Company i.e. wholesale distribution of medical devices and other allied products. The acquisition shall be completed by February 15, 2026.
The company has also received approval for entering into a binding Memorandum of Understanding for acquiring 51% stake in Anand Chemiceutics, subject to satisfactory completion of due diligence and execution of the definitive agreements. The Board of Directors of the Company, at its meeting held on November 12,2025, inter alia, considered and approved the same.
Entero Healthcare Solutions is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
